[HTML][HTML] Exosomes in plasma of patients with ovarian carcinoma: potential biomarkers of tumor progression and response to therapy

…, M Michalak, H Drzewiecka, D Szpurek… - Gynecology & …, 2013 - ncbi.nlm.nih.gov
Background: In patients with Ovarian Cancer (OvCa) exosomes released by tumor cells are
present in the plasma and could be involved in tumor progression. This study examines the …

External validation of the IOTA ADNEX model performed by two independent gynecologic centers

…, K Dyczkowski, A Stachowiak, S Sajdak, D Szpurek… - Gynecologic …, 2016 - Elsevier
Objectives The external, two-center validation of the IOTA ADNEX model for differential
diagnosis of adnexal tumors. Methods A total of 204 patients with adnexal masses (134 …

[HTML][HTML] Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases

…, M Murias, S Szubert, A Woźniak, D Szpurek… - Cell death & …, 2016 - nature.com
Although both incidence and aggressiveness of ovarian malignancy rise with age, the exact
reason for this tendency, in particular the contribution of senescent cells, remains elusive. In …

[HTML][HTML] Colorectal cancer-promoting activity of the senescent peritoneal mesothelium

…, H Piotrowska, M Murias, A Woźniak, D Szpurek… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Gastrointestinal cancers metastasize into the peritoneal cavity in a process controlled by
peritoneal mesothelial cells (HPMCs). In this paper we examined if senescent HPMCs can …

Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells

…, K Matuszkiewicz, S Szubert, R Moszyński, D Szpurek… - Cellular Oncology, 2016 - Springer
Purpose After the seeding ovarian cancer cells into the peritoneal cavity, ascitic fluid creates
a microenvironment in which these cells can survive and disseminate. The exact nature of …

[HTML][HTML] Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo

…, K Maksin, H Piotrowska, A Woźniak, D Szpurek… - Clinical & Experimental …, 2016 - Springer
It is believed that senescent cells contribute to the progression of primary and metastatic
tumors, however, the exact mechanisms of this activity remain elusive. In this report we show …

Malignant ascites determine the transmesothelial invasion of ovarian cancer cells

…, P Uruski, S Szubert, D Szpurek… - The international journal …, 2017 - Elsevier
The exact role of malignant ascites in the development of intraperitoneal ovarian cancer
metastases remains unclear. In this report we sought to establish if ascites can determine …

Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors

…, P Uruski, S Szubert, R Moszyński, D Szpurek… - Medical Oncology, 2016 - Springer
Although undifferentiated tumors are the most lethal among all ovarian cancer histotypes,
the exact reasons for this situation are unclear. This report was aimed at investigating …

Role of osteopontin in differential diagnosis of ovarian tumors

R Moszynski, S Szubert, D Szpurek… - Journal of Obstetrics …, 2013 - Wiley Online Library
Aim The aim of this study was to evaluate the role of the serum osteopontin (OPN) level as a
biomarker for discriminating between malignant and benign ovarian tumors. Furthermore …

Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells

…, A Woźniak, E Naumowicz, D Szpurek… - Free Radical Biology …, 2017 - Elsevier
The cancer-promoting activity of senescent peritoneal mesothelial cells (HPMCs) has
already been well evidenced both in vitro and in vivo. Here we sought to determine if …